Fiduciary Alliance’s GSK GSK Stock Holding History

Fiduciary Alliance’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578K	Hold	11,017	–	–	0.04%	341
2026 Q1	$637K	Sell	11,017 -599	-5%	-$32.5K	0.04%	338
2025 Q4	$570K	Sell	11,616 -425	-4%	-$19.8K	0.04%	324
2025 Q3	$520K	Buy	12,041 +195	+2%	+$7.62K	0.03%	340
2025 Q2	$455K	Buy	11,846 +407	+4%	+$15.6K	0.03%	334
2025 Q1	$443K	Sell	11,439 -88	-0.8%	-$3.22K	0.04%	272
2024 Q4	$390K	Buy	+11,527	New	+$415K	0.04%	264
2023 Q3	–	Sell	-176	Closed	-$6.27K	–	484
2023 Q2	$6.27K	Buy	+176	New	+$6.31K	﹤0.01%	652
2023 Q1	–	Sell	-176	Closed	-$6.18K	–	429
2022 Q4	$6.18K	Buy	+176	New	+$5.86K	﹤0.01%	487

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fiduciary Alliance's GSK Position: Q2 2026 in Review

Fiduciary Alliance held its GSK (GSK) position steady in Q2 2026 at 11,017 shares worth $578K. The position accounts for 0.04% of the portfolio, ranked #341.

Fiduciary Alliance first reported a position in GSK in Q4 2022 and has held it in 9 quarters since. The position peaked at $637K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Fiduciary Alliance held 11,017 shares of GSK worth $578K as of Q2 2026.
Fiduciary Alliance left its GSK share count unchanged in Q2 2026.
GSK made up 0.04% of Fiduciary Alliance's portfolio in Q2 2026, its #341 holding.
Fiduciary Alliance first reported a position in GSK in Q4 2022 and has held it in 9 quarters since.
Fiduciary Alliance's GSK position peaked at $637K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.